American Medical Compliance
AUGUST 12, 2022
Food and Drug Administration is planning to develop updated versions of booster vaccines that are specifically targeted to protect against Omnicron and its variants. Furthermore, the FDA is encouraging COVID-19 vaccine manufacturers to update their booster shots to protect against BA.4 Second COVID-19 Booster.
American Medical Compliance
AUGUST 18, 2022
Receiving one negative test result does n0t necessarily mean that someone doesn’t have COVID-19. According to the FDA, people conducting at home tests should perform multiple COVID-19 tests over the course of several days. However, a PCR COVID-19 test has a higher detection rate of 95%.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Medisys Compliance
APRIL 20, 2022
On 4 th April 2022, CMS announced that more than 59 million Americans with Medicare Part B, including those enrolled in a Medicare Advantage plan, now have access to Food and Drug Administration (FDA) approved, authorized, or cleared over-the-counter COVID-19 tests at no cost.
Healthcare IT News - Telehealth
MAY 7, 2021
For example, the data analytics team designed an algorithm to sort and pull relevant data from the records of more than 100,000 patients who had been diagnosed with COVID-19, identifying those at highest risk of complications from the virus. "We decided to implement self-scheduling for the COVID-19 vaccine.
HIT Consultant
AUGUST 18, 2021
Ronan Brown, SVP and Head of Integrated Global Compliance, IQVIA. The world has been in urgent need of COVID-19 vaccines, treatments, and diagnostic tools. Food and Drug Administration (FDA), along with greater flexibility around mandates on alternatives to traditional clinical information. About Ronan Brown.
YouCompli
MARCH 29, 2023
CMS Updates to beneficiary PHE waivers that matter to healthcare compliance Sharon Parsley, JD, MBA, CHC, CHRC, contributes regularly to the YouCompli blog. In this article, she discusses several issues that hospitals and health systems need to consider as a result of the scheduled end of the COVID-19 public health emergency.
SQA
JUNE 10, 2021
Backgrounder – Government of Canada Investments in Biomanufacturing, Development of COVID-19 Vaccines and Therapeutics, and Research, 18 May 2021. That’s why the government is implementing a multi-faceted procurement strategy to provide a COVID-19 vaccine to every Canadian who wants one by September.
Expert insights. Personalized for you.
52 
Let's personalize your content